$DMAC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DiaMedica Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in DiaMedica Therapeutics Inc.. Get notifications about new insider transactions in DiaMedica Therapeutics Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2021 | DMAC | DiaMedica Therapeu ... | Giuffre Randall Michael | Director | Grant | A | 8.23 | 7,441 | 61,239 | 116,029 | 108.6 K to 116 K (+6.85 %) |
| Jan 04 2021 | DMAC | DiaMedica Therapeu ... | Parsons James T. | Director | Grant | A | 8.23 | 7,745 | 63,741 | 21,947 | 14.2 K to 21.9 K (+54.53 %) |
| Jan 04 2021 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Grant | A | 8.23 | 9,719 | 79,987 | 80,565 | 70.8 K to 80.6 K (+13.72 %) |
| Dec 04 2020 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Buy | P | 5.24 | 5,000 | 26,200 | 70,846 | 65.8 K to 70.8 K (+7.59 %) |
| Dec 04 2020 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Buy | P | 5.50 | 5,000 | 27,497 | 65,846 | 60.8 K to 65.8 K (+8.22 %) |
| Nov 23 2020 | DMAC | DiaMedica Therapeu ... | Giuffre Randall Michael | Director | Buy | P | 4.26 | 15,000 | 63,912 | 108,588 | 93.6 K to 108.6 K (+16.03 %) |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Gilman Sydney A. | VP, Regulatory Affa ... | Option Exercise | A | 4.64 | 17,500 | 81,200 | 17,500 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Kellen Scott | CFO and Secretary | Option Exercise | A | 4.64 | 35,000 | 162,400 | 35,000 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Pauls Dietrich John | President and CEO | Option Exercise | A | 4.64 | 56,000 | 259,840 | 56,000 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | ALCORN HARRY W JR | Chief Medical Offic ... | Option Exercise | A | 4.64 | 35,000 | 162,400 | 35,000 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Giuffre Randall Michael | Director | Option Exercise | A | 4.64 | 13,306 | 61,740 | 13,306 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Giuffre Randall Michael | Director | Grant | A | 4.59 | 7,784 | 35,729 | 93,588 | 85.8 K to 93.6 K (+9.07 %) |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Parsons James T. | Director | Option Exercise | A | 4.64 | 13,306 | 61,740 | 13,306 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Parsons James T. | Director | Grant | A | 4.59 | 8,102 | 37,188 | 14,202 | 6.1 K to 14.2 K (+132.82 %) |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Parsons James T. | Director | Option Exercise | A | 4.64 | 13,306 | 61,740 | 13,306 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Parsons James T. | Director | Grant | A | 4.59 | 8,102 | 37,188 | 14,202 | 6.1 K to 14.2 K (+132.82 %) |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Option Exercise | A | 4.64 | 19,220 | 89,181 | 19,220 | |
| Jun 02 2020 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Grant | A | 4.59 | 10,168 | 46,671 | 60,846 | 50.7 K to 60.8 K (+20.06 %) |
| Nov 05 2019 | DMAC | DiaMedica Therapeu ... | Gilman Sydney A. | VP, Regulatory Affa ... | Option Exercise | A | 4.00 | 50,000 | 200,000 | 50,000 | |
| Aug 19 2019 | DMAC | DiaMedica Therapeu ... | Kellen Scott | CFO and Secretary | Buy | P | 2.43 | 3,000 | 7,290 | 10,290 | 7.3 K to 10.3 K (+41.15 %) |
| Aug 19 2019 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Buy | P | 2.56 | 7,840 | 20,039 | 50,678 | 42.8 K to 50.7 K (+18.30 %) |
| Aug 16 2019 | DMAC | DiaMedica Therapeu ... | ALCORN HARRY W JR | Chief Medical Offic ... | Buy | P | 2.67 | 7,260 | 19,365 | 8,260 | 1,000 to 8.3 K (+726.00 %) |
| Aug 16 2019 | DMAC | DiaMedica Therapeu ... | Pauls Dietrich John | President and CEO | Buy | P | 2.68 | 1,000 | 2,677 | 30,804 | 29.8 K to 30.8 K (+3.36 %) |
| Aug 16 2019 | DMAC | DiaMedica Therapeu ... | ALCORN HARRY W JR | Chief Medical Offic ... | Buy | P | 2.67 | 7,260 | 19,365 | 8,260 | 1,000 to 8.3 K (+726.00 %) |
| Aug 16 2019 | DMAC | DiaMedica Therapeu ... | Pauls Dietrich John | President and CEO | Buy | P | 2.68 | 1,000 | 2,677 | 30,804 | 29.8 K to 30.8 K (+3.36 %) |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | Xiao Zhenyu | Director | Option Exercise | A | 4.60 | 12,950 | 59,570 | 12,950 | |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | Verdoorn Todd A. | Chief Scientific Of ... | Option Exercise | A | 4.60 | 71,025 | 326,715 | 71,025 | |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Option Exercise | A | 4.60 | 18,700 | 86,020 | 18,700 | |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | Pauls Dietrich John | President and CEO | Option Exercise | A | 4.60 | 264,000 | 1,214,400 | 264,000 | |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | Parsons James T. | Director | Option Exercise | A | 4.60 | 12,950 | 59,570 | 12,950 | |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | Kellen Scott | CFO and Secretary | Option Exercise | A | 4.60 | 99,750 | 458,850 | 99,750 | |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | Giuffre Randall Michael | Director | Option Exercise | A | 4.60 | 12,950 | 59,570 | 12,950 | |
| Jun 26 2019 | DMAC | DiaMedica Therapeu ... | ALCORN HARRY W JR | Chief Medical Offic ... | Option Exercise | A | 4.60 | 125,000 | 575,000 | 125,000 | |
| May 31 2019 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Buy | P | 2.80 | 19,000 | 53,200 | 42,838 | 23.8 K to 42.8 K (+79.70 %) |
| May 28 2019 | DMAC | DiaMedica Therapeu ... | Kellen Scott | CFO and Secretary | Buy | P | 2.94 | 4,000 | 11,770 | 7,290 | 3.3 K to 7.3 K (+121.58 %) |
| Mar 29 2019 | DMAC | DiaMedica Therapeu ... | ALCORN HARRY W JR | Chief Medical Offic ... | Gift | G | 0.00 | 150 | 0 | 1,000 | 1.2 K to 1,000 (-13.04 %) |
| Mar 29 2019 | DMAC | DiaMedica Therapeu ... | ALCORN HARRY W JR | Chief Medical Offic ... | Buy | P | 4.46 | 150 | 668 | 1,150 | 1,000 to 1.2 K (+15.00 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | Xiao Zhenyu | Director | Buy | P | 4.00 | 3,250 | 13,000 | 7,100 | 3.9 K to 7.1 K (+84.42 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | Verdoorn Todd A. | Chief Scientific Of ... | Buy | P | 4.00 | 1,000 | 4,000 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | Pilnik Richard D. | Director | Buy | P | 4.00 | 6,250 | 25,000 | 23,838 | 17.6 K to 23.8 K (+35.54 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | Pauls Dietrich John | President and CEO | Buy | P | 4.00 | 5,000 | 20,000 | 29,804 | 24.8 K to 29.8 K (+20.16 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | Parsons James T. | Director | Buy | P | 4.00 | 2,250 | 9,000 | 6,100 | 3.9 K to 6.1 K (+58.44 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | Kellen Scott | CFO and Secretary | Buy | P | 4.00 | 1,250 | 5,000 | 3,290 | 2 K to 3.3 K (+61.27 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | Giuffre Randall Michael | Director | Buy | P | 4.00 | 11,250 | 45,000 | 85,804 | 74.6 K to 85.8 K (+15.09 %) |
| Dec 11 2018 | DMAC | DiaMedica Therapeu ... | ALCORN HARRY W JR | Chief Medical Offic ... | Buy | P | 4.00 | 1,000 | 4,000 | 1,000 | 0 to 1,000 |
Page: 1